例如:"lncRNA", "apoptosis", "WRKY"

Macrophage migration inhibitory factor (MIF) promotes rat airway muscle cell proliferation and migration mediated by ERK1/2 and FAK signaling.

Cell Biol. Int.2018 Jan;42(1):75-83. doi:10.1002/cbin.10863. Epub 2017 Sep 20
Haibing Lan 1 , Nan Wang 2 , Yu Chen 1 , Xiaojing Wang 3 , Yuanqi Gong 1 , Xiefei Qi 1 , Yaling Luo 4 , Fang Yao 3
Haibing Lan 1 , Nan Wang 2 , Yu Chen 1 , Xiaojing Wang 3 , Yuanqi Gong 1 , Xiefei Qi 1 , Yaling Luo 4 , Fang Yao 3
+ et al

[No authors listed]

Author information
  • 1 Department of the Intensive Care Unit, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • 2 Department of Laboratory Medicine, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, Guangdong 510095, China.
  • 3 Research Center of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou North Avenue, Guangzhou 510515, China.
  • 4 Department of Respiratory Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

摘要


Macrophage migration inhibitory factor (MIF) is an inflammatory mediator that contributes to asthmatic airway remodeling; however, little is known regarding the effects of MIF on airway smooth muscle cells (ASMCs). In the present study, we found that an enhanced expression of MIF promoted ASMC proliferation, increased the population of cells in the S/G2 phase, downregulated P21 expression, and upregulated cyclin D1, cyclin D3, and Cdk6 expression. In addition, the apoptosis of ASMCs was significantly decreased in response to MIF overexpression, compared with the negative control. Moreover, MIF facilitated the migration of ASMCs by upregulating the expression of matrix metalloproteinase (MMP)-2. Finally, we showed that MIF increased the phosphorylation of extracellular regulated protein kinases (ERK) 1/2 and focal adhesion kinase (FAK), which are associated with proliferation and migration. In conclusion, this study demonstrated that MIF overexpression promotes the proliferation and migration of ASMCs by upregulating the activity of the ERK1/2 and FAK signaling pathways in these cells, further indicating that inhibition of MIF may prove to be an effective strategy for treating asthma patients with airway remodeling.

KEYWORDS: airway smooth muscle cells, macrophage migration inhibitory factor, migration, proliferation